This whitepaper argues that lyophilization is a margin-improvement lever for reagent kit and in vitro diagnostics manufacturers, not just a technical/logistics choice.
What the piece covers
- Frames lyophilization as a growing industry trend, noting demand for lyophilization expertise is outpacing the supply of trained specialists
- Lists core benefits: reduced refrigerated warehouse requirements, lower shipping costs, simplified end-user handling, and longer shelf life
- Frames the tradeoff as higher upfront processing cost versus long-term margin and efficiency benefits
- Flags product types best suited to lyophilization: those currently on cold-chain logistics, requiring user pipetting, or with short expiration windows
Lyophilized Products: Benefits for Reagent Kits
Lyophilization is a hot topic in biotech and pharma, as numerous suppliers are introducing lyo-ready or pre-lyophilized products to the marketplace. As a result, demand for lyophilization services is growing at a rate that exceeds the current number of trained experts. Benefits of lyophilized products include reduced refrigerated warehouse requirements, lower shipping costs, simplified product use, and longer shelf life. The future of lyophilization continues to balance higher upfront costs versus long-term benefits as improvements in conventional lyophilization technology efficiency are sought. If your product uses cold chain logistics, requires user pipetting, or has a short expiration window, there are significant benefits to introducing a lyophilized version.
Read the whole white paper here and learn more about lyophilization and it’s benefits for reagent kits and in vitro diagnostics.
